Latest market price
144.43
+0.98+0.68%
OverviewShort InterestFilings
AXSMQT22Axsome Therapeutics, Inc.·NASDAQ
144.43+0.68%

Latest SEC Filings

Form category
DescriptionFilingDocument
Sep 03, 20264Statement of changes in beneficial ownership
Aug 10, 20268-KCurrent report
Aug 10, 202610-QQuarterly report
Aug 07, 20264Statement of changes in beneficial ownership
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 15, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
Jun 09, 20268-KCurrent report
Jun 03, 20268-KCurrent report
Jun 02, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
May 04, 202610-QQuarterly report
May 04, 20268-KCurrent report
#1 / 25 of 284
Page
▼
/ 12